Problem statement: Answer the MCQ question.
Question: Which compound has a -5.121\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] Cc1cc(NC(=O)CC2CCCC2)n(-c2nc3ccccc3[nH]2)n1
[b] COc1ccc(CCNC(=O)Cn2nc(C(=O)O)c3ccccc3c2=O)cc1OC
[c] O=C(NCc1cccs1)c1cc(-c2ccccc2)nn1CC1CC(c2cccc([N+](=O)[O-])c2)=NO1
[d] O=C(Nc1nnc(C23CC4CC(CC(C4)C2)C3)s1)c1ccco1
[e] O=C(CCNS(=O)(=O)c1ccc(Br)cc1)NC1CCC(O)CC1
Answer: a. Cc1cc(NC(=O)CC2CCCC2)n(-c2nc3ccccc3[nH]2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)CC2CCCC2)n(-c2nc3ccccc3[nH]2)n1
Cc1cc(NC(=O)CC2CCCC2)n(-c2nc3ccccc3[nH]2)n1
N-[2-(1H-benzimidazol-2-yl)-5-methylpyrazol-3-yl]-2-cyclopentylacetamide